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What Dermatologists Do Not Know about Smallpox
Vaccination: Results from a Worldwide Electronic
Survey
Robert P. Dellavalle1,2, Lauren F. Heilig2,3, Shayla O. Francis2, Kathryn R. Johnson2, Eric J. Hester2,
Kristie M. McNealy2, Lisa M. Schilling3,4 and William L. Weston2
The risk of a bioterrorist attack with smallpox has increased owing to breakthroughs in the de novo synthesis of
long-chain DNA molecules. Although the leading roles of dermatologists in diagnosing recent outbreaks of
cutaneous anthrax and monkeypox demonstrate the importance of dermatologist preparedness for
bioterrorism, dermatologist knowledge regarding smallpox vaccination has not been extensively examined.
We conducted a cross-sectional worldwide electronic survey of all members of the American Academy of
Dermatology with available e-mail addresses. The response rate was 23% (1,303/5,723): 34% of respondents were
women, 52% were age 50 or older, 85% practiced in the US, and 90% reported English as their primary language.
Less than 37% indicated the Centers for Disease Control and Prevention estimated rate of death owing to
smallpox vaccination (1 in 1,000,000), and many failed to identify vaccination contraindications: previous
myocardial infarction (83%), angina (83%), congestive heart failure (78%), steroid eye drop use (65%), and the
non-emergency vaccination of those younger than age 18 (95%). Widespread dermatologist smallpox
vaccination knowledge deficits pinpoint opportunities for educational efforts.
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INTRODUCTION
US smallpox vaccination policy has generated heated debate
(Beane, 2004; Kaiser, 2005). Although US physicians and
patients are increasingly unwilling to volunteer for smallpox
vaccination (Blendon et al., 2003; Everett et al., 2003, 2004;
Kuhles and Ackman, 2003; Benin et al., 2004; Centers for
Disease Control and Prevention, 2005a), advances in long
molecule DNA synthesis that facilitate in vitro synthesis of
viral genomes have recently heightened concerns about
smallpox bioterrorism attacks (Tian et al., 2004).
This study assessed dermatologist knowledge regarding
smallpox vaccination.
RESULTS
The response rate for the electronic survey (Online Appendix
A) was 23% (1,303/5,723). Thirty-four percent of respondents
were women, 52% were age 50 or older, 85% practiced in
the USA, and 90% reported English as their primary
language. Respondents reflected American Academy of
Dermatology (AAD) fellow sex and age distributions, and
over-represented fellows in the USA (Online Appendix B).
Questions regarding smallpox vaccination adverse events
and contraindications were imbedded among 29 questions
addressing the practices and attitudes of dermatologists
regarding smallpox vaccination and responder demo-
graphics. Owing to skip patterns determined by the answers
provided, all responders completing the full survey viewed at
least 21 of the 29 questions. Response rates per question for
these 21 questions ranged from 99% for the first question
regarding types of media exposure through which smallpox
educational information had been obtained to 90% for the
fill-in question requesting country of practice. Except for one
nurse, all respondents were physicians. Most respondents
(71%) saw patients in a town of 100,000 or more people, and
46% practiced in a group setting.
Few respondents (17%) reported recent vaccination for
smallpox in the preceding 5 years (16.8% US vs 27.3%
outside the US) (relative risk for smallpox vaccination
among US respondents¼ 0.6; 95% confidence interval¼ 0.3,
1.3). Eighty-three percent of those who had been given
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a choice regarding whether or not to be vaccinated stated
that vaccine safety had influenced their decision (Table 1).
Most reported receiving recent information on smallpox from
journal articles (91%), medical mailings (85%), Internet
information (72%), medical lectures (71%), or newspaper
articles (70%).
Dermatologists were frequently not in agreement (15%
overestimated, 22% underestimated, 26% unsure) with the
CDC estimate of death owing to smallpox vaccination (1 in
1,000,000) (Table 2). Most identified immunosuppression
(97%), eczema (93%), breastfeeding (58%), and a household
member with a history of eczema (57%) as contraindications
to smallpox vaccination, but few identified myocardial
infarction (17%), angina (17%), congestive heart failure
(22%), use of steroid eye drops (35%), and non-emergency
vaccination of those under age 18 (5%).
The answers of those who responded before the third
e-mail invitation on October 8, 2004 (n¼877) were
compared with the answers of those responding after October
8, 2004 (n¼ 426). No significant differences between the two
groups were found with regard to sex, age, vaccination status,
or agreement that a smallpox attack was likely in the next 12
months.
DISCUSSION
In 2001, the CDC recommended smallpox vaccination for
medical or laboratory personnel exposed to non-highly
attenuated orthopoxviruses (Rotz LD et al., 2001). In
Table 1. Smallpox vaccination status
Yes No Not sure
Has smallpox vaccination been
available in your country in the past
5 years?
618 (52) 415 (35) 165 (14)
Has smallpox vaccination been
available to you in the past 5 years?
526 (44) 479 (40) 205 (17)
Were you able to freely choose
whether or not to receive smallpox
vaccination?
448 (87) 51 (10) 15 (3)
What factors influenced your smallpox vaccination decision?
Level of risk of a smallpox
outbreak
370 (83) 77 (17)
Vaccination safety 367 (83) 76 (17)
Recommendations by healthcare
organizations
267 (61) 168 (39)
Recommendations by healthcare
providers
256 (59) 178 (41)
Vaccination convenience 125 (29) 305 (71)
Patriotism 88 (20) 347 (80)
Planned travel to other countries 71 (16) 364 (84)
Recommendations by employer 62 (14) 371 (86)
Incentives for vaccination 20 (5) 414 (95)
Have you recently been vaccinated
(within 5 years) for smallpox?
89 (17) 432 (82) 3 (1)
Year
2004 2 (2)
2003 64 (74)
2002 20 (23)
2001 1 (1)
2000 0 (0)
Table 2. Smallpox vaccination knowledge
Number (%)
Approximately, what is the current estimate of the rate of non-lethal serious
side effects from smallpox vaccination, including blindness and
hospitalization?
1 in 1,000,000 or more rare 128 (11)
1 in 100,0001 379 (31)
1 in 10,000 249 (20)
1 in 1,000 140 (12)
Not sure 323 (27)
Approximately, what is the current estimate of the rate of death from
smallpox vaccination?
1 in 10,000,000 or more rare 270 (22)
1 in 1,000,0001 448 (37)
1 in 100,000 139 (11)
1 in 10,000 46 (4)
Not sure 313 (26)
Yes No Not sure
Which of the following do you believe to be contraindications to smallpox
vaccination?2
Immunosuppression 1184 (97) 11 (1) 26 (2)
Eczema 1133 (93) 47 (4) 38 (3)
Breastfeeding mother 698 (58) 211 (17) 298 (25)
Household member with a history
of eczema
690 (57) 354 (29) 166 (14)
Use of steroid eye drops 420 (35) 441 (37) 344 (29)
Congestive heart failure 267 (22) 642 (54) 290 (24)
Previous myocardial infarction 206 (17) 759 (64) 228 (19)
Angina 198 (17) 761 (64) 239 (20)
Under the age of 18 years 63 (5) 1044 (88) 84 (7)
1Best answer based on current CDC information.
2All conditions listed are contraindications to vaccination. A complete list
of contraindications is available at: http://www.bt.cdc.gov/agent/small-
pox/vaccination/contraindications-clinic.asp.
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December 2002, President George W. Bush announced that
those ‘‘deployed or who may deploy to certain high threat
areas be vaccinated’’ (CDC, 2005b). In 2003, the CDC
recommended vaccination ‘‘for persons designated by public
health authorities to conduct investigation and follow-up of
initial smallpox cases that might necessitate direct patient
contact.’’ Each state and territory has been advised to
establish and maintain at least one smallpox response team
consisting of members who have previously been vaccinated
(Wharton et al., 2003). Cardiac complications from smallpox
vaccination precipitated a CDC press release recommending
deferral for heart patients volunteering for smallpox vaccina-
tion in March 2003 (Casey et al., 2005). Our survey occurred
in late 2004. As of December 5, 2005, over 920,000
Department of Defense operational forces and healthcare
workers have been vaccinated (CDC, 2005c; Office of the
Assistant Secretary of Defense, 2005).
Dermatologists would likely be among the first consultants
summoned to perform skin biopsies and help distinguish
smallpox from chickenpox, monkeypox, orf, and other
diagnoses. Although dermatologists in this survey indicated
willingness to be vaccinated if a smallpox outbreak occurred,
the current low rate of recent vaccination parallels that of
other healthcare workers (Kuhles and Ackman, 2003; Benin
et al., 2004; CDC, 2005a).
Smallpox vaccination confers immunity to smallpox for
3–5 years with waning immunity thereafter (CDC, 2005d;
Hatakeyama et al., 2005). The CDC identifies the risk of
serious side effects from vaccination, including the spread of
the live virus used in the vaccinia inoculation to other sites of
the body or to other people, to occur in 1 in 1,000 persons
(CDC, 2005e). The CDC also reports that 14 to 52 in
1,000,000 vaccinees will experience life-threatening reac-
tions including eczema vaccinatum, progressive vaccinia,
and postvaccinal encephalitis, and one to two in 1,000,000
vaccinees may die as a result. The CDC’s contraindications to
smallpox vaccination for persons unexposed to smallpox
currently include having eczema or other skin conditions,
immunosuppression, pregnancy or plans to become pregnant
within 1 month of vaccination, an allergy to the vaccine or its
components, age younger than 1 year in an emergency
setting or younger than 18 years in a non-emergency setting,
breastfeeding, use of steroid eye drops, history of a heart
condition diagnosed by a physician, or three or more of the
following cardiac risk factors diagnosed by a physician: high
blood pressure; high blood cholesterol; diabetes; first-degree
relative with a heart condition before age 50; and currently
smoking cigarettes (CDC, 2005e).
Most responders’ answers did not reflect CDC guidelines
for smallpox vaccination of persons with heart disease or
under the age of 18 years, a finding consistent with nearly
half of healthcare workers not feeling well informed about the
risks and benefits of smallpox vaccination (Yih et al., 2003).
Physician advice has also deviated from widely publicized
public health guidelines for other infectious agents (Chan
et al., 1997; Deng et al., 2006), highlighting the need for new
approaches for physicians learning of public health messages
(Armstrong and Parsa-Parsi, 2005).
This study has strengths and weaknesses:
(a) The response rate was 23% reflecting increasing limita-
tions in obtaining high response rates to electronic
surveys (Sheehan, 2001). We were, however, encour-
aged to achieve a response rate similar to those of many
other published electronic surveys (Sheehan, 2001;
Hester et al., 2004) despite the decreased tendency of
physicians to respond to surveys compared with other
sample populations (Asch et al., 1997).
(b) The potential for response bias for e-mail surveys is
greater than for mailed or telephone surveys (Braithwaite
et al., 2003). Voluntary response to an electronic survey
likely selected for responses from physicians more
interested in and knowledgeable about smallpox. The
results therefore likely overestimate vaccination rates
and underestimate knowledge deficits regarding small-
pox vaccination.
(c) Survey invitations were emailed directly by AAD admin-
istration in the hope of improving response rate as well as
to ensure anonymity of respondents. However, as no
e-mail addresses or other identifying variables for AAD
members were provided to the authors, examination of
non-responder bias was not possible. Late responders
have been suggested to display biases that might be
accentuated in non-responders (Armstrong and Overton,
1977). Comparison of early and late responders to this
survey showed no significant differences.
(d) The questionnaire was not available in languages other
than English, deterring response from non-native English
speakers and creating a possible language barrier for the
10% of respondents whose primary language was not
English.
(e) This study did not assess dermatologists’ smallpox
diagnostic skill, an important parameter for successful
response to a bioterrorist attack.
Smallpox vaccination remains a topic of high importance and
publicity. This study highlights the need to more effectively
inform dermatologists about facts that may influence deci-
sions regarding smallpox vaccination and provides descrip-
tive information for improving public health smallpox
communications with dermatologists and other potential first
responders worldwide (Institute of Medicine, 2005). Future
studies might investigate dermatologists’ smallpox diagnostic
skill, how they view the importance of knowledge of
smallpox, and how better knowledge might impact manage-
ment of a bioterrorist attack.
MATERIALS AND METHODS
AAD fellows with active e-mail addresses (5,723 of 8,293) were
emailed an introductory letter containing a link to the electronic-
based questionnaire on August 9, 2004. Up to three further
elicitations were emailed to non-responders on September 17,
October 8, and December 9, 2004. The AAD mediated the emailing
of members to protect member e-mail address confidentiality and
prevent the authors from identifying responding and non-responding
AAD members individually.
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The survey (Online Appendix A) consisted of 29 questions
addressing: (1) knowledge of efficacy, risks, and contraindications to
smallpox vaccination, (2) perceived threat of a smallpox bioterrorism
attack, (3) attitudes about vaccination, (4) personal vaccination history,
and (5) demographic data. Information regarding contraindications to
smallpox vaccination was obtained from the CDC (CDC, 2005e).
The questionnaire was designed and data collected using Survey
Monkey, an Internet-based electronic survey resource (www.survey-
monkey.com). Invitees were informed that all responses would
remain anonymous and only be analyzed in aggregate. Data
analysis, including relative risks with 95% confidence intervals,
was performed using SAS Version 9 (Cary, NC). This study received
Colorado Multiple Institutional Review Board approval (no. 03-677).
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